MANIFEST study: Does the BET inhibitor CPI-0610 show synergy with ruxolitinib in MF? MPN Hub 3:38 4 years ago 180 Далее Скачать
MANIFEST study: Does the BET inhibitor CPI-0610 show synergy with ruxolitinib in myelofibrosis? MPN Hub 3:57 3 years ago 68 Далее Скачать
Pelabresib (CPI-0610): a novel BET inhibitor for MF VJHemOnc – Video Journal of Hematology & HemOnc 2:08 4 years ago 376 Далее Скачать
CPI-0610 Demonstrates Activity in Patients With Myelofibrosis After Ruxolitinib Failure Targeted Oncology 1:05 5 years ago 508 Далее Скачать
BET Inhibitor pelabresib (CPI-0610) and ruxolitinib for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:27 5 years ago 397 Далее Скачать
MANIFEST: pelabresib (CPI-0610) + ruxolitinib in advanced myelofibrosis patients VJHemOnc – Video Journal of Hematology & HemOnc 3:49 4 years ago 314 Далее Скачать
Dr. Kremyanskaya on MANIFEST Trial With CPI-0610 in Myelofibrosis OncLive 1:44 4 years ago 55 Далее Скачать
MANIFEST study of pelabresib (CPI-0610) in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:06 5 years ago 598 Далее Скачать
MANIFEST study: Should CPI-0610 be used as an add-on to ruxolitinib in patients with advanced MF? MPN Hub 1:59 4 years ago 46 Далее Скачать
MANIFEST: pelabresib (CPI-0610) shows promise in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:33 3 years ago 144 Далее Скачать
Dr. Kremyanskaya on Effect of CPI-0610 in Patients With Myelofibrosis OncLive 1:00 4 years ago 90 Далее Скачать
Phase I/II study of a novel BET inhibitor, BMS-986158, alone & with ruxolitinib or fedratinib in MF VJHemOnc – Video Journal of Hematology & HemOnc 2:04 1 year ago 84 Далее Скачать
What do the preliminary results of the MANIFEST trial say about CPI-0610 in treating MF? MPN Hub 6:06 3 years ago 69 Далее Скачать
Phase I dose-escalation study of the BET inhibitor INCB057643 in R/R myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 183 Далее Скачать
CPI-0610 Shows Clinical Activity in Patients With Myelofibrosis Targeted Oncology 1:53 4 years ago 83 Далее Скачать
MANIFEST update: pelabresib clinical and pathological investigations VJHemOnc – Video Journal of Hematology & HemOnc 2:10 2 years ago 264 Далее Скачать
Novel therapies for myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:41 4 years ago 275 Далее Скачать
ABBV-744 and Mivebresib: BET inhibitors in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:18 3 years ago 249 Далее Скачать
The first in-human Phase I study of a BET inhibitor for the treatment of NHL VJHemOnc – Video Journal of Hematology & HemOnc 4:24 8 years ago 1 742 Далее Скачать
